The product, owned by Swiss healthcare products firm Devirex, is due to be brought to market in the UK in Q1 2017.
It is understood the search for an agency is already underway, with Ingenuity helping with the agency selection process.
Lipivir and its parent company were unavailable for comment when contacted by PRWeek.
Devirex was founded in 2006, and is based in Walchwil, near Zürich.
